The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118599872 11859987 2 F 20160620 20151222 20160704 EXP ZA-AUROBINDO-AUR-APL-2015-11571 AUROBINDO 31.00 YR F Y 0.00000 20160704 OT ZA ZA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118599872 11859987 1 PS NEVIRAPINE. NEVIRAPINE 1 Unknown 400 MG, DAILY U 77521 400 MG
118599872 11859987 2 C LAMIVUDINE. LAMIVUDINE 1 Unknown 300 MG, DAILY Y U 0 300 MG
118599872 11859987 3 C TENOFOVIR DISOPROXIL FUMARATE. TENOFOVIR DISOPROXIL FUMARATE 1 Unknown 300 MG, DAILY Y U 0 300 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118599872 11859987 1 HIV infection
118599872 11859987 2 HIV infection
118599872 11859987 3 HIV infection

Outcome of event

Event ID CASEID OUTC COD
118599872 11859987 LT
118599872 11859987 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118599872 11859987 Cheilitis
118599872 11859987 Conjunctivitis
118599872 11859987 Eosinophil count increased
118599872 11859987 Epidermal necrosis
118599872 11859987 Eye pain
118599872 11859987 Inappropriate schedule of drug administration
118599872 11859987 Malaise
118599872 11859987 Odynophagia
118599872 11859987 Overdose
118599872 11859987 Rash
118599872 11859987 Skin hyperpigmentation
118599872 11859987 Stevens-Johnson syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found